Liz Parrish: Paving the way in cutting edge gene therapy innovations to treat diseases of aging

2 August 2018

Recently, an article was published on the website Outside publicising Liz Parrish, founder of BioViva, a company focused on health and longevity. BioViva believes that it is on the...

Read more
alzheimers

A Novel Gene Therapy To Treat One Of The World’s Biggest Growing Chronic Disease: Dementia and Alzhiemer’s

17 July 2018

Research studies indicate that telomerase gene therapy may not only reverse Alzheimer’s Disease and other dementias, but it may even protect people from developing...

Read more

Bioviva: Helping reduce the burden of chronic aging

11 July 2018

What BioViva does as a company is vitally important. Throughout our lifetime, it is possible to achieve amazing things, but time is always a...

Read more

What prompted Elizabeth Parrish to set up BioViva?

4 July 2018

2013 was a difficult year for Elizabeth Parrish. Upon finding out that her son had type 1 diabetes. A condition with dangerous continuations of...

Read more
No Images

BioViva’s aims to be an advanced medicinal product access platform. To this end BioViva is committed to the following:

17 May 2018

Bridging stakeholders with biotechnology Accelerated path to human trials Growing knowledge base Ensuring dependability BioViva is a platform to expedite the development of drugs...

Read more

Overexpression of genes to suppress dsRNA innate immunity

8 March 2018

BioViva scientist Ali Fallah et al have worked on the reprogramming potential of GCS (germline derived stem cells) the self-renewal capacity of which makes...

Read more

What’s All The Buzz? BioViva’s Platform For Expedited Drug Development

28 February 2018

Aging is the root cause of the diseases of old age, and this disease burden causes an immense amount of suffering to individuals and...

Read more

Gene Therapy using anti-inflammatory cytokines promising against MS

30 January 2018

BioViva scientist Ali Fallah and his team work on novel gene therapy using anti-inflammatory cytokines and show that these can be a promising approach...

Read more

Source of stem cells that are easily available and raise no ethical concerns

24 January 2018

Research by BioViva scientist Ali Fallah: ” In this study, we describe an efficient approach for stable knockdown of adenosine kinase (ADK) using lentiviral...

Read more